Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online July 15, 2020.
Article Versions
- Latest version (May 25, 2020 - 04:00).
- You are currently viewing a Latest version of this article (July 15, 2020 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2020 The Journal of Rheumatology
Author Information
- W. Winn Chatham and
- Randy Q. Cron
- University of Alabama at Birmingham, Department of Medicine, Division of Clinical Immunology and Rheumatology; Department of Pediatrics, Division of Rheumatology, Birmingham, Alabama, USA.
Drs. Cron and Chatham are co-principal investigators on an investigator-initiated clinical trial to study interleukin 1 blockade in treating secondary HLH in children and adults. The trial is funded by Swedish Orphan Biovitrum Inc. (SOBI; ClinicalTrials.gov: NCT02780583), which manufactures anakinra. Dr. Cron serves as a consultant to SOBI. Dr. Chatham has served as a consultant to SOBI.
Address correspondence to Dr. R. Cron, Children’s of Alabama, Division of Rheumatology, 1600 7th Ave. S., CPPN, Suite G10, Birmingham, Alabama 35233-1711, USA. E-mail: rcron@peds.uab.edu